114 related articles for article (PubMed ID: 8626694)
41. Binding specificity and modulation of the ApoA-I promoter activity by homo- and heterodimers of nuclear receptors.
Tzameli I; Zannis VI
J Biol Chem; 1996 Apr; 271(14):8402-15. PubMed ID: 8626539
[TBL] [Abstract][Full Text] [Related]
42. The function of retinoid X receptors on negative thyroid hormone response elements.
Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ
Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079
[TBL] [Abstract][Full Text] [Related]
43. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation.
Shao ZM; Sheikh MS; Rishi AK; Dawson MI; Li XS; Wilber JF; Feng P; Fontana JA
Exp Cell Res; 1995 May; 218(1):1-8. PubMed ID: 7737350
[TBL] [Abstract][Full Text] [Related]
44. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
45. The orphan receptor TAK1 acts as a repressor of RAR-, RXR- and T3R-mediated signaling pathways.
Hirose T; Apfel R; Pfahl M; Jetten AM
Biochem Biophys Res Commun; 1995 Jun; 211(1):83-91. PubMed ID: 7779113
[TBL] [Abstract][Full Text] [Related]
46. Half-site arrangement of hybrid glucocorticoid and thyroid hormone response elements specifies thyroid hormone receptor complex binding to DNA and transcriptional activity.
Yen PM; Ikeda M; Wilcox EC; Brubaker JH; Spanjaard RA; Sugawara A; Chin WW
J Biol Chem; 1994 Apr; 269(17):12704-9. PubMed ID: 8175681
[TBL] [Abstract][Full Text] [Related]
47. Reconstitution of thyroid hormone receptor and retinoic acid receptor function in the fission yeast Schizosaccharomyces pombe.
Sande S; Privalsky ML
Mol Endocrinol; 1994 Nov; 8(11):1455-64. PubMed ID: 7877615
[TBL] [Abstract][Full Text] [Related]
48. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
[TBL] [Abstract][Full Text] [Related]
49. Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors.
Williams GR; Harney JW; Moore DD; Larsen PR; Brent GA
Mol Endocrinol; 1992 Oct; 6(10):1527-37. PubMed ID: 1333048
[TBL] [Abstract][Full Text] [Related]
50. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.
Barettino D; Bugge TH; Bartunek P; Vivanco Ruiz MD; Sonntag-Buck V; Beug H; Zenke M; Stunnenberg HG
EMBO J; 1993 Apr; 12(4):1343-54. PubMed ID: 8096810
[TBL] [Abstract][Full Text] [Related]
51. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
52. Thyroid hormone receptor-alpha inhibits retinoic acid-responsive gene expression and modulates retinoic acid-stimulated neural differentiation in mouse embryonic stem cells.
Lee LR; Mortensen RM; Larson CA; Brent GA
Mol Endocrinol; 1994 Jun; 8(6):746-56. PubMed ID: 7935490
[TBL] [Abstract][Full Text] [Related]
53. Thyroid hormone and retinoic acid receptors form heterodimers with retinoid X receptors on direct repeats, palindromes, and inverted palindromes.
Schräder M; Carlberg C
DNA Cell Biol; 1994 Apr; 13(4):333-41. PubMed ID: 8011161
[TBL] [Abstract][Full Text] [Related]
54. Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.
Niessen RW; Rezaee F; Reitsma PH; Peters M; de Vijlder JJ; Sturk A
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):263-70. PubMed ID: 8761481
[TBL] [Abstract][Full Text] [Related]
55. Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements.
Ikeda M; Rhee M; Chin WW
Endocrinology; 1994 Oct; 135(4):1628-38. PubMed ID: 7925126
[TBL] [Abstract][Full Text] [Related]
56. Thyroid hormone response element half-site organization and its effect on thyroid hormone mediated transcription.
Paquette MA; Atlas E; Wade MG; Yauk CL
PLoS One; 2014; 9(6):e101155. PubMed ID: 24971931
[TBL] [Abstract][Full Text] [Related]
57. Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities.
Chassande O; Fraichard A; Gauthier K; Flamant F; Legrand C; Savatier P; Laudet V; Samarut J
Mol Endocrinol; 1997 Aug; 11(9):1278-90. PubMed ID: 9259319
[TBL] [Abstract][Full Text] [Related]
58. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.
Juge-Aubry CE; Gorla-Bajszczak A; Pernin A; Lemberger T; Wahli W; Burger AG; Meier CA
J Biol Chem; 1995 Jul; 270(30):18117-22. PubMed ID: 7629123
[TBL] [Abstract][Full Text] [Related]
59. Homodimer and heterodimer DNA binding and transcriptional responsiveness to triiodothyronine (T3) and 9-cis-retinoic acid are determined by the number and order of high affinity half-sites in a T3 response element.
Force WR; Tillman JB; Sprung CN; Spindler SR
J Biol Chem; 1994 Mar; 269(12):8863-71. PubMed ID: 8132622
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition.
Soprano DR; Chen LX; Wu S; Donigan AM; Borghaei RC; Soprano KJ
Oncogene; 1996 Feb; 12(3):577-84. PubMed ID: 8637715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
